SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-20-095599
Filing Date
2020-08-14
Accepted
2020-08-14 16:39:42
Documents
1
Group Members
CURT LABELLEPRIVATE MEDICAL EQUITY, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2027332-2_sc13da.htm SC 13D/A 89725
  Complete submission text file 0001104659-20-095599.txt   91063
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Subject) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90395 | Film No.: 201106006
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 FIFTH AVENUE SUITE 1404 NEW YORK NY 10017
Business Address
Ianchulev Tsontcho (Filed by) CIK: 0001728916 (see all company filings)

Type: SC 13D/A